• Home
  • NEW DAY MEDICINE
  • 10 (72) 2024
  • 57 -10 (72) 2024 - Nuralieva D.M., Mukhamedova M.G. - ASSESSMENT OF BIOCHEMICAL PARAMETERS IN MILITARY PATIENTS WITH POST-COVID CARDIAC SYNDROMES

57 -10 (72) 2024 - Nuralieva D.M., Mukhamedova M.G. - ASSESSMENT OF BIOCHEMICAL PARAMETERS IN MILITARY PATIENTS WITH POST-COVID CARDIAC SYNDROMES

ASSESSMENT OF BIOCHEMICAL PARAMETERS IN MILITARY PATIENTS WITH POST-COVID CARDIAC SYNDROMES

Nuralieva D.M. - Military Medical Academy of the Armed Forces of the Republic of Uzbekistan Tashkent, Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

Mukhamedova M.G. - Military Medical Academy of the Armed Forces of the Republic of Uzbekistan Tashkent, Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

Kireev V.V. - Military Medical Academy of the Armed Forces of the Republic of Uzbekistan Tashkent, Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

Azizova F.F. - Military Medical Academy of the Armed Forces of the Republic of Uzbekistan Tashkent, Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

Resume

The aim of the study. To analyze changes in biochemical blood parameters in military patients with post-Covid cardiac syndromes. Material and methods. All patients underwent a comprehensive biochemical study, which included determination of the level of liver enzymes ALT, AST, bilirubin, urea, creatinine, and total protein using a standard set of reagents. Conclusion. In patients with PCCS, it was characterized by changes in biochemical blood parameters. In the post-Covid period, deviations in biochemical parameters were noted in all groups of patients, a decrease in vitamin D, serum electrolytes and an increase in C-reactive protein.

Key words: post-Covid cardiac syndrome (PCCS), chronic persistent myoendocarditis (CPME), chronic fibrinous pericarditis (CFP), chronic heart failure (CHF), аlanine aminotransferase (ААT), аspartate aminotransferase (AST), total cholesterol (TC), low-density lipoprotein (LDL) , very low density lipoproteins (VLDL), triglycerides (TG).

First page

341

Last page

345

For citation:Nuralieva D.M., Mukhamedova M.G., Kireev V.V., Azizova F.F. - ASSESSMENT OF BIOCHEMICAL PARAMETERS IN MILITARY PATIENTS WITH POST-COVID CARDIAC SYNDROMES//New Day in Medicine 10(72)2024 341-345 https://newdayworldmedicine.com/en/new_day_medicine/10-72-2024

List of References

  1. Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation. 2021;44(1):13-34. https://doi.org/10.1007/s10753-020-01337-3
  2. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases. 2021;53(10):737-754. https://doi.org/10.1080/23744235.2021.1924397
  3. Callard F, Perego E. How and why patients made Long Covid. Social Science and Medicine (1982). 2021;268:113426. https://doi.org/10.1016/j.socscimed.2020.113426
  4. Bansal R, Gubbi S, Koch CA. COVID-19 and Chronic Fatigue Syndrome: An Endocrine Perspective [published online ahead of print, 2021 Dec 3]. Journal of Clinical and Translational Endocrinology. 2021;100284. https://doi.org/10.1016/j.jcte.2021.100284
  5. Fernández-Lázaro D, Sánchez-Serrano N, Mielgo-Ayuso J, García-Hernández JL, González-Bernal JJ, Seco-Calvo J. Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? Journal of Clinical Medicine. 2021;10(24):5799. https://doi.org/10.3390/jcm10245799
  6. Guerrero Caballero S, Bilbao Fernández S. [Persistence of SARS-CoV-2 virus as an etiologic cause of long-lasting symptomatology in patients with persistent COVID-19]. Medicina General y de Familia. 2021;10:85-90. https://doi.org/10.24038/mgyf.2021.027
  7. Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, Hägglöf T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O’Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639-644. https://doi.org/10.1038/s41586-021-03207-w
  8. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid — mechanisms, risk factors, and management. British Medical Journal. 2021;374:n1648. https://doi.org/10.1136/bmj.n1648
  9. Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. COVID-19 y diabetes mellitus: una relación bidireccional. Clinica e Investigacion en Arteriosclerosis. 2021;33(3):151-157. https://doi.org/10.1016/j.arteri.2020.10.001
  10. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;94:91-95. https://doi.org/10.1016/j.ijid.2020.03.017

    file

    download